Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
A piece by Orlando Sentinel highlighted an article published on AJMC.com, the website of The American Journal of Managed Care® (AJMC®). The article, “New CMS Model Aims to Lower Insulin Costs for Seniors,” noted an announcement by CMS on the Part D Senior Savings Model, allowing Medicare Part D prescription drug plans to offer plan choices that provide a range of insulins to beneficiaries, at a maximum $35 co-pay per 30-day supply throughout the benefit year.
An article by Market Watch cited a piece published on AJMC.com, titled “Low-Income Women Less Likely to Keep Jobs After Breast Cancer Treatment.” The piece spotlighted findings linking women with breast cancer with a 2-fold increased likelihood of returning to work after treatment if their employer makes accommodations for them, but workplace accommodation and job retention were found to be significantly lower for low-income and minority women.
An article by AJMC®’s sister site The Center for Biosimilars® was referenced in a piece by The Pharma Letter, titled “The Purple Book: Transition to a single online source.” The article, “FDA Launches Searchable Database Intended to Replace Static Purple Book Lists,” detailed an announcement by the FDA launching the first phase of its improvement to the Purple Book by moving from a list format to a searchable database, so the public can more easily search biosimilar and biologic products.
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
HMO and EPO Insurance Plans More Likely to Promote Use of Biosimilars
November 21st 2023Health plan type highly influences the likelihood of biosimilar uptake, with low-flexibility insurance plans more likely to have patients who either switched to a biosimilar or were initiated on a biosimilar.
Read More
Oncology Onward: A Conversation With Dr Debra Patt of Texas Oncology
August 1st 2023Debra Patt, MD, PhD, MBA, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for episode 2 of our newest podcast, "Oncology Onward: Conversations With Innovators and Changemakers in Cancer Care."
Listen
Therapists’ Perspectives on Access to Telemental Health Among Medicaid-Enrolled Youth
November 10th 2023This qualitative study elucidates therapists’ perspectives on barriers to and facilitators of access to telemental health among Medicaid-enrolled youth served by a large safety-net organization.
Read More